title: Discrepant findings in immune responses to JC virus in patients receiving natalizumab.
authors.forename: Chen S
authors.initials: CS
authors.lastname: Tan
authors.forename: Yiping
authors.initials: Y
authors.lastname: Chen
authors.forename: Raphael P
authors.initials: RP
authors.lastname: Viscidi
authors.forename: R Philip
authors.initials: RP
authors.lastname: Kinkel
authors.forename: Marion C
authors.initials: MC
authors.lastname: Stein
authors.forename: Igor J
authors.initials: IJ
authors.lastname: Koralnik
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000941:Antigens / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use; D007577:JC Virus / Q000378:metabolism; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism; D000069442:Natalizumab; D013601:T-Lymphocytes / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000941:Antigens; D007155:Immunologic Factors; D000069442:Natalizumab; D016899:Interferon-beta